Quick Takeaways
- RENAISSANCE TECHNOLOGIES LLC filed SCHEDULE 13G for COLLEGIUM PHARMACEUTICAL, INC Common Stock, par value $0.001 per share.
- Disclosed ownership: 5.1%.
- Date of event: 02 Aug 2024.
RENAISSANCE TECHNOLOGIES LLC - 02 Aug 2024 SCHEDULE 13G Report for COLLEGIUM PHARMACEUTICAL, INC Common Stock, par value $0.001 per share
- Filing Manager
- RENAISSANCE TECHNOLOGIES LLC
- Reporting Manager
- Renaissance Technologies LLC
- Shares outstanding
- 32,219,241 shares
- Disclosed Ownership
- 1,656,069 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2024, 14:39:22 UTC
- Date of event
- 02 Aug 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"RENAISSANCE TECHNOLOGIES LLC disclosed 5.1% ownership in COLLEGIUM PHARMACEUTICAL, INC Common Stock, par value $0.001 per share on 02 Aug 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2024, 14:39.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | 5.1% | 1,656,069 | 1,656,069 | 0 | Brian Felczak | Chief Financial Officer | |
| Renaissance Technologies Holdings Corporation | 5.1% | 1,656,069 | 1,656,069 | 0 | Brian Felczak | Vice President |